Leadership Overview
Altasciences has 9 executives leading key functions including strategy, operations, and medical affairs.
Driven by a commitment to advancing drug development, Altasciences provides comprehensive preclinical and clinical services, manufacturing, and analytical support, positioning itself as a vital partner in the pharmaceutical research landscape.
Driven by a commitment to advancing drug development, Altasciences provides comprehensive preclinical and clinical services, manufacturing, and analytical support, positioning itself as a vital partner in the pharmaceutical research landscape.
Leadership Roles at Altasciences
Marie-Helene Raigneau - Chief Executive Officer
Marie-Helene Raigneau, the Chief Executive Officer at Altasciences, directs the overarching corporate strategy and operational execution for the contract research organization. Raigneau guides the company's mission to accelerate drug development through integrated preclinical and clinical services. This leadership role involves fostering innovation across bioanalytical services and manufacturing capabilities. By ensuring alignment with market demands, Raigneau drives the company's expansion and impact within the global pharmaceutical sector. The Chief Executive Officer's focus remains on enhancing client partnerships and delivering high-quality research outcomes. Marie-Helene Raigneau's strategic vision shapes Altasciences' position as a key CRO partner.
Christopher Perkin - President & Chief Executive Officer
Christopher Perkin, the President & Chief Executive Officer at Altasciences, spearheads the company's strategic direction and global operations. Perkin oversees the delivery of comprehensive preclinical and clinical services, ensuring seamless integration of bioanalytical and manufacturing capabilities. This executive leadership role involves driving growth initiatives and expanding Altasciences' market presence across North America and beyond. By championing operational excellence, Perkin ensures the company meets the evolving needs of its pharmaceutical and biotechnology clients. The President & Chief Executive Officer's mandate includes fostering a culture of scientific rigor and client-centricity. Christopher Perkin's leadership guides Altasciences in its mission to support critical drug development pathways.
Steven Mason - Co-Chief Operating Officer
Steven Mason, the Co-Chief Operating Officer at Altasciences, manages critical aspects of the company's operational infrastructure and service delivery. Mason focuses on optimizing internal processes and resource allocation to support the preclinical and clinical services offered. This leadership position involves enhancing the efficiency of bioanalytical and manufacturing operations, ensuring timely project completion for clients. By collaborating with other senior leaders, Steven Mason drives operational excellence across various departments. The Co-Chief Operating Officer's responsibilities include implementing best practices to maintain high standards in research and development support. Mason's efforts contribute directly to Altasciences' capacity to serve the pharmaceutical industry effectively.
Robert Sabelli - Co-Chief Operating Officer
Robert Sabelli, the Co-Chief Operating Officer at Altasciences, directs key operational functions, particularly focusing on the integration and scaling of services. Sabelli oversees the strategic deployment of resources to enhance the company's preclinical and clinical offerings, including bioanalytical and manufacturing support. This executive role involves driving operational improvements that directly impact client project timelines and outcomes. By ensuring robust operational frameworks, Robert Sabelli supports Altasciences' growth and its ability to manage complex research projects. The Co-Chief Operating Officer's purview includes optimizing supply chain logistics and facility management to bolster service delivery. Sabelli's contributions are vital to maintaining Altasciences' reputation for reliability.

Charles Spainhour - President and CSO
Charles Spainhour, the President and CSO at Altasciences, directs the scientific strategy and innovation across the organization's research and development initiatives. Spainhour oversees the scientific integrity and advancement of preclinical and clinical services, ensuring cutting-edge methodologies are employed. This leadership position involves guiding the scientific teams in areas such as bioanalytical services and drug metabolism studies. By fostering a culture of scientific excellence, Charles Spainhour enhances Altasciences' capabilities to tackle complex research challenges. The President and CSO's mandate includes driving scientific collaborations and staying at the forefront of CRO advancements. Spainhour's expertise is fundamental to Altasciences' scientific credibility and service quality.
Nicole Maciolek - Executive Vice President & Chief Revenue Officer, Services
Nicole Maciolek, the Executive Vice President & Chief Revenue Officer, Services at Altasciences, leads the commercial strategy and revenue generation for the company's diverse service offerings. Maciolek drives business development initiatives across preclinical, clinical, bioanalytical, and manufacturing services. This critical role involves cultivating strong client relationships and identifying new market opportunities within the pharmaceutical and biotech sectors. By aligning sales efforts with service delivery capabilities, Nicole Maciolek ensures sustained revenue growth and market penetration. The Executive Vice President & Chief Revenue Officer, Services' focus is on expanding Altasciences' client base and maximizing service utilization. Maciolek's commercial acumen is central to the company's financial performance.
Catherine Konidas - Chief Administrative Officer
Catherine Konidas, the Chief Administrative Officer at Altasciences, oversees the essential administrative functions that support the company's operational and strategic objectives. Konidas manages human resources, legal affairs, and corporate governance, ensuring compliance and efficient internal operations. This executive role involves developing policies and procedures that foster a productive and compliant work environment across all service areas, including preclinical and clinical operations. By optimizing administrative processes, Catherine Konidas enhances the overall efficiency of Altasciences. The Chief Administrative Officer's responsibilities are crucial for maintaining the company's operational stability and supporting its growth trajectory. Konidas ensures that administrative support aligns with the company's mission.
Gaetano Morelli - Chief Medical Officer
Gaetano Morelli, the Chief Medical Officer at Altasciences, provides critical medical and scientific oversight for the company's clinical research services. Morelli guides the design and execution of clinical trials, ensuring adherence to the highest ethical and scientific standards. This leadership role involves interpreting clinical data and advising clients on therapeutic development strategies. By leveraging extensive medical expertise, Gaetano Morelli enhances the value of Altasciences' clinical offerings. The Chief Medical Officer's focus is on ensuring patient safety and the scientific validity of research conducted. Morelli's insights are instrumental in positioning Altasciences as a trusted partner in drug development.
Joel Woods - Senior Director, Information Technology & Strategic Planning
Joel Woods, the Senior Director, Information Technology & Strategic Planning at Altasciences, directs the company's technology infrastructure and long-term strategic technology initiatives. Woods oversees the implementation and management of IT systems that support all operational areas, including preclinical and clinical services, bioanalytical labs, and manufacturing. This leadership role involves ensuring data security, system reliability, and the adoption of innovative technologies to enhance efficiency and client support. By aligning IT strategy with business objectives, Joel Woods drives technological advancement within Altasciences. The Senior Director's focus is on leveraging technology to optimize research processes and support strategic growth. Woods plays a key part in the company's digital transformation.
Explore Leadership Teams in Business Services
Syneos Health, founded in 1998, is a global biopharmaceutical research and development services company that provides integrated clinical and commercial solutions. The company operates across more than 110 countries, offering expertise in clinical trials, medical affairs, and commercial strategy to help bring therapies to market faster. Syneos Health leverages advanced technologies and data-driven insights to address modern healthcare challenges and improve patient outcomes. The company serves pharmaceutical, biotechnology, and healthcare organizations worldwide with specialized services including clinical research, consulting, and marketing. Headquartered in the United States with significant operations across Europe, Asia Pacific, Africa, and the Americas, Syneos Health maintains a global presence in the life sciences industry.
Company Leadership

EW
Founded in 1967 and headquartered in Northwood, Ohio, NAMSA Inc is a Medical Research Organization (MRO), accelerating medical device product development through integrated laboratory, clinical research, and regulatory and reimbursement consulting services.
Company Leadership AS

RS
Pacific Northwest National Laboratory is one of the United States Department of Energy national laboratories, managed by the Department of Energy's Office of Science. The main campus of the laboratory is in Richland, Washington.
Company Leadership
CN

AS
Sysmex Corp. engages in the development, manufacture, import, export, and sale of clinical laboratory instruments, reagents, and software used in in-vitro diagnostics. It also provides clinical laboratory testing of blood, urine, and other specimens. Its products include instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care (POC) testing. It operates through the following geographical segments: Japan, Americas, Europe, China, and Asia Pacific. The company was founded on February 20, 1968 and is headquartered in Kobe, Japan.
Company Leadership
AK
DB